GHSI — Guardion Health Sciences Share News
0.000.00%
- $4.22m
- -$10.60m
- $12.25m
Brief: Guardion Health Sciences To Wind Down VectorVision Business Operations And Focus On Exploiting VectorVision Intellectual Property
Brief: Guardion Health Sciences Issues Letter To Shareholders
Brief: Guardion Health Sciences Appoints Experienced Healthcare Executive Michaela Griggs To Its Board Of Directors
Brief: Guardion Health Sciences Announces Quarterly Loss Per Share $0.12
Brief: Guardion Health Sciences Inc Entered Into An Agreement To Terminate Lease On Its San Diego, California Corporate Office And Main Warehouse Facility
Brief: Guardion Health Sciences Says Entered Into Lease Termination Agreement With Cal-Sorrento
Brief: Guardion Health Sciences Announces Quarterly Loss Per Share Of $0.19
Brief: Guardion Health Sciences To Be Added To The Russell 3000 Index
Brief: Guardion Health Sciences Says CFO Andrew Schmidt To Step Down
Guardion Health Sciences: Rises on $26 mln deal to buy supplement company
Brief: Guardion Health Sciences To Acquire Activ Nutritional And Its Viactiv Brand Of Products
Brief: Guardion Health Sciences Reports Qtrly Loss Per Share Of $0.13
Brief: Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin Product
Brief: Guardion Health Regains Compliance With Nasdaq Minimum Bid Price Rule
Brief: Guardion Health Sciences Announces 1-For-6 Reverse Stock Split Effective Pre-Market Opening On Monday, March 1, 2021
Brief: Guardion Health Sciences - May Offer & Sell Shares Of Common Stock Having Aggregate Offering Price Of Up To $25 Million
Brief: Guardion Health Sciences - Malaysia's Hwgb Advised Co That Astramern Astra H Granted Product Registration Approval By Malaysian Npra
Brief: Nasdaq Grants Guardion Health Sciences An Extension To March 15, To Regain Compliance With The $1 Minimum Bid Price Rule
Brief: Guardion Health Sciences Inc enters Into Equity Distribution Agreement With Maxim Group Llc